aTyr Pharma, Inc.
ATYR
$0.58
$0.024.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 57.42M | 66.51M | 78.69M | 90.20M | 80.35M |
| Total Receivables | 426.00K | 477.00K | 873.00K | 1.04M | 498.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 518.00K | 586.00K | 677.00K | 1.77M | 6.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 58.36M | 67.58M | 80.24M | 93.01M | 87.49M |
|
|
|||||
| Total Current Assets | 58.36M | 67.58M | 80.24M | 93.01M | 87.49M |
| Net Property, Plant & Equipment | 9.78M | 10.13M | 10.38M | 10.78M | 11.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.69M | 1.95M | 2.38M | 2.86M | 2.94M |
| Total Assets | 69.83M | 79.65M | 93.00M | 106.65M | 101.53M |
|
|
|||||
| Total Accounts Payable | 3.24M | 2.76M | 3.89M | 4.06M | 3.88M |
| Total Accrued Expenses | 6.69M | 7.46M | 9.79M | 10.19M | 10.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.46M | 1.49M | 1.47M | 1.43M | 1.33M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.40M | 11.70M | 15.15M | 15.68M | 15.53M |
|
|
|||||
| Total Current Liabilities | 11.40M | 11.70M | 15.15M | 15.68M | 15.53M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.84M | 10.21M | 10.57M | 10.93M | 11.35M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.23M | 21.91M | 25.72M | 26.61M | 26.88M |
|
|
|||||
| Common Stock & APIC | 676.12M | 674.96M | 673.65M | 672.44M | 641.38M |
| Retained Earnings | -627.26M | -616.96M | -606.16M | -592.20M | -566.46M |
| Treasury Stock & Other | -68.00K | -70.00K | -8.00K | -1.00K | -75.00K |
| Total Common Equity | 48.79M | 57.93M | 67.48M | 80.24M | 74.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.79M | 57.93M | 67.48M | 80.24M | 74.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -194.00K | -193.00K | -192.00K | -191.00K | -189.00K |
| Total Equity | 48.59M | 57.74M | 67.29M | 80.04M | 74.66M |
|
|
|||||